tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
US Market

Coherus Biosciences (CHRS) Cash flow

1,659 Followers

Coherus Biosciences Cash Flow

CHRS's free cash flow for Q4 2025 was $-19.72M. For the 2025 fiscal year, CHRS's free cash flow was decreased by $-118.07M and operating cash flow was $-19.72M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -138.51M$ -20.44M$ -174.88M$ -241.12M$ -37.43M
Investing Cash Flow
$ 375.09M$ 230.32M$ 144.64M$ -166.85M$ -138.41M
Financing Cash Flow
$ -273.70M$ -186.97M$ 69.60M$ 54.33M$ 51.88M
End Cash Position
$ 89.12M$ 126.25M$ 102.89M$ 63.99M$ 417.63M
Free Cash Flow
$ -138.51M$ -20.44M$ -175.17M$ -243.16M$ -38.72M
Currency in USD

Coherus Biosciences Cash Flow